Now Offering Moderna, JJ, Pfizer Bivalent Vaccines for Adults & Kids 5 and Older

Get Healthy!

Results for search "Cystic Fibrosis".

Health News Results - 8

While early diagnosis of cystic fibrosis can prevent permanent lung damage, newborn screening often looks only for genetic mutations more common in white people than those found in people of color, a new study finds.

“Newborn screenings are meant to be a public health measure that is equal across populations, but in practice, we are actually creating disparities because children of colo...

More than 160,000 people around the world have cystic fibrosis, and supplementing with vitamins C and E could help reduce the damaging inflammation in their lungs, according to new research.

"Cystic fibrosis is a genetic disease that is associated with increased inflammation, and like many inflammatory diseases, it comes with a large amount of

  • By Cara Murez HealthDay Reporter
  • |
  • October 3, 2022
  • |
  • Full Page
  • Babies who are white appear to get diagnostic appointments for cystic fibrosis earlier than babies of several other races and ethnicities, new research shows.

    This can cause gaps in care and outcomes.

    While it is recommended that infants who have an initial positive screening for cystic fibrosis be furt...

    Special needs children often require out-of-network care from specialists, which means more out-of-pocket costs and extra stress for families, a new study finds.

    "In the U.S., the reality is that the more health care needs you have, especially from specialists, the greater chance you will find your needs won't be met, even if you have private insurance coverage," said lead author Wendy Xu...

    Hundreds of new proteins that may be linked to cystic fibrosis have been identified by researchers and could point the way to better treatments for people with the genetic disease.

    There is no cure for cystic fibrosis,...

    A three-drug combo that significantly improves lung function in cystic fibrosis patients could benefit 90% of people with the life-threatening disease, a new study suggests.

    It included patients with a single copy of the most common genetic mutation for the disease.

    Results of the international phase 3 clinical trial led the U.S. Food and Drug Administration to approve ...

    A new drug to treat most cystic fibrosis patients has been approved by the U.S. Food and Drug Administration.

    Trikafta (elexacaftor/ivacaftor/tezacaftor) is the first triple combination therapy available to treat patients with the most common cystic fibrosis mutation. Its list price is $311,000 a year, same as one of the maker's earlier treatments for the genetic disease.

    Tr...

    Viruses and bacteria are the culprits behind the infectious diseases that plague humans. Researchers recently turned one against the other, using viruses to wipe out a potentially life-threatening bacterium in a 15-year-old girl with cystic fibrosis.

    This old-time approach to battling bacterial infections might be worth another look in these days of antibiotic-resistant bacteria, a ne...